 Today, I have the pleasure of speaking with Greg Fenton from Zen Graphene. How are you today, Greg? I am wonderful, Tracy. How are you doing? Well, the much-awaited news has just crossed the wire here in the last 24 hours. Let's talk about that, shall we? So yes, we received, finally, our Health Canada approval for our ZenGuard masks with our partner Tree Boar. It's a process that started about a little over five months ago. Our masks, all graphene-based masks, went under review by Health Canada, and we were required to do significantly more testing on our masks to ensure that they were safe. The regulator was doing their job. They wanted to make sure that products for Canadians were safe and safe to use. And we knew that, but we were confident through the whole process that we would get our approval because we had done significant testing to ensure that our material was not only safe, but it actually adhered to the mask surface. So we knew it was coming. We just knew it was a matter of time, and we know that it probably took a little bit longer time than people had anticipated. But the conclusion here is that we got our approval. Now we're ready to go and start selling masks to help people protect themselves against nasty pathogens. The response from the market has been explosive. How will you deal with your exponential demands on the company for these masks? Great question. We have been preparing for this moment for a number of months now. We indicated back in April that we were in the process of scaling up our production capacity of our coating that actually goes on to the masks. So we started pilot scale scale up back in May, and we're up to the million mask equivalent per day of coating production in our pilot scale. And we will be up to about 25 million masks per day by the end of this year. So we've been active in the background while we're waiting for this approval, and we just can't wait to start getting the product into the market. Of course, I know they answered this question already, but I think there's a lot of shareholders and investors out there that may not understand how big the demand for masks still are. Can you talk to this topic, please? Sure, Tracy. And that was one of the questions that I got early on when the vaccines first came out. They said, oh, the need for masks is going to go away. So we did a lot of research in this area. And it's estimated that was 1.5 trillion single-use masks utilized globally through the pandemic so far. So we took a very conservative estimate of that, about 60%, which gets us to about 900 billion run rate. Even if we were to make a 1% move into that market, you're still talking about 9 billion masks. So we think there's going to be huge demand for masks going forward, particularly masks that provide additional protection to the people that are using them. And that will be the Zengard mask. And of course, for those out there that are going scrambling, they're seeing the volume around ZEN, and they're wondering, what are these competitive elements around these Zengrafin masks that are making the Zengard mask the mask everybody wants? Well, our mask will be the gold standard. It will be a best-in-class, I don't want to say the best-in-class, but one of the best-in-class. We've demonstrated that it kills bacteria, fungi, viruses. We've proven that it does not hamper the efficiency of a mask. It actually enhances it. So it truly is a better product. And that's why we were so happy with our Health Canada approval yesterday. We just validated that this is a great product and it's going to be on the shelves very, very shortly. We do have significant demand for it from around the globe. But more importantly, this really unlocks a lot of new opportunities for Zengrafin. This, you know, not only can we sell masks in Canada, but there's other jurisdictions around the globe that will utilize the Health Canada approval to allow masks to be sold into their jurisdictions. As well, this really opens the door for application of our coding in other spaces like the HVAC market, for example. That's exactly where I was going next was, I think that this is just a hint of where Zengrafin is going next. Can you talk to that at all? It is. This was a major milestone that we needed to hit. And this was really the key that opened the door. And I think the people in the market will be surprised at how much interest there is in this product. We know what we've been seeing, but we've sort of sat on that and just we're, you know, minding our time till we got regulatory approval. Now that it's a safe product, I think people are going to be very happy with where this company goes over, you know, the coming quarters. And of course, my next question is the obvious one, which is how can I get a box? Well, they will, we're working rapidly with our partners at TreeBor to start producing masks. And TreeBor will have them through various distributorships and will be available on their website shortly as well. So they will be available to the general public, but there's significant demand out of the hospital and long-term care facilities for this better product. Very exciting news, very exciting news. Greg, please join us again in a couple of weeks so we can get an update on how this approval has impacted Zangrafi. Thank you. Thank you, Tracy. Have a good day.